Oral Oncology
Volume 46, Issue 9 , Pages 662-666 , September 2010

Cytology and histology have limited added value in prognostic models for salivary gland carcinomas

  • Marc P. van der Schroeff

      Affiliations

    • Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus Medical Center, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. Tel.: +31 107033106; fax: +31 107033102.
    • ,
  • Chris H.J. Terhaard

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Marjan H. Wieringa

      Affiliations

    • Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Frank R. Datema

      Affiliations

    • Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Robert J. Baatenburg de Jong

      Affiliations

    • Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus Medical Center, Rotterdam, The Netherlands

Received 5 May 2010 ,Revised 15 June 2010 ,Accepted 16 June 2010.

References 

  1. Spiro RH, Armstrong JA, Harrison L, Geller NL, Lin SY, Strong EW. Carcinoma of the major salivary glands: recent trends. Arch Otolaryngol Head Neck Surg. 1989;115(3):316–321
  2. Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary parotid malignancies. A clinical and pathological review. Arch Otolaryngol Head Neck Surg. 1991;117(3):307–315
  3. Calearo C, Pastore A, Storchi OF, Polli G. Parotid gland carcinoma: analysis of prognostic factors. Acta Otorhinolaryngol. 1998;107:969–973
  4. Bell RB, Dierks EJ, Homer L, Potter BE. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg. 2005;63(7):917–928
  5. Lima RA, Tavares MR, Dias FL, Kligerman J, Nascimento MF, Barbosa MM, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg. 2005;133(5):702–708
  6. Harbo G, Bundgaard T, Pedersen D, Søgaard H, Overgaard J. Prognostic indicators for malignant tumours of the parotid gland. Clin Otolaryngol Allied Sci. 2002;27(6):512–516
  7. Bhattacharyya N, Fried MP. Determinants of survival in parotid gland carcinoma: a population-based study. Am J Otolaryngol. 2005;26(1):39–44
  8. Zbaren P, Schupbach J, Nuyens M, Stauffer E, Greiner R, Hausler R. Carcinoma of the parotid gland. Am J Surg. 2003;186(1):57–62
  9. Renehan AG, Slevin NJ, McGurk M. Clinico-pathological and treatment-related factors influencing survival in parotid cancer. Br J Cancer. 1999;80(8):1296–1300
  10. Spiro RH, Dubner S. Salivary gland tumors. Curr Opin Oncol. 1990;2(3):589–595
  11. Van der Poorten VLM, Balm AJM, Hilgers FJM, Tan IB, Loftus-Coll BM, Keus RB, et al. The development of a prognostic score for patients with parotid carcinoma. Cancer. 1999;85(9):2057–2067
  12. Hocwald E, Korkmaz H, Yoo GH, Adsay V, Shibuya TY, Abrams J, et al. Prognostic factors in major salivary gland cancer. Laryngoscope. 2001;111(8):1434–1439
  13. Carrillo JF, Vazquez R, Ramirez-Ortega MC, Cano A, Ochoa-Carillo FJ, Onate-Ocana LF. Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer. 2007;109(10):2043–2051
  14. Terhaard CHJ, Lubsen H, Van der Tweel I, Hilgers FJ, Eijkenboom WM, Marres HA, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck. 2004;26(8):681–692[discussion 692–693]
  15. Terhaard CHJ, Lubsen H, Rasch CR, Levendag PC, Kaanders HH, Tjho-Heslinga RE, et al. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys. 2005;61(1):103–111
  16. Terhaard CHJ, Lubsen H, Tan B, Merkx T, van der Laan B, Baatenburg de Jong RJ, et al. Facial nerve function in carcinoma of the parotid gland. Eur J Cancer. 2006;42(16):2744–2750
  17. Terhaard CH, van der Schroeff MP, van Schie K, Eerenstein SE, Lubsen H, Kaanders JH, et al. The prognostic role of comorbidity in salivary gland carcinoma. Cancer. 2008;113(7):1572–1579
  18. Jones AV, Craig GT, Speight PM, Franklin CD. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol. 2008;44(4):407–417
  19. van Buuren S, Brand J, Groothuis-Oudshoorn C, Rubin DB. Fully conditional specifications in multivariate imputation. Draft Available from: <http://web.inter.nl.net/users/S.van.Buuren/publications/FCS%20(revised%20Jan%202005).pdf>.
  20. Little R, An H. Robust likelihood-based analysis of multivariate data with missing values. Statistica Sinica. 2004;(14):933–952
  21. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543–2546
  22. Steyerberg EW, Eijkemans MJ, Harrell FE, Habbema JDF. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000;19(8):1059–1079
  23. Steyerberg EW, Harrell FE, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JDF. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54(8):774–781
  24. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–387
  25. Team RDC. An introduction to R.R. Foundation for statistical computing, Vienna, Austria; 2006.
  26. Team RDC R. A language and environment for statistical computing. Vienna, Austria: R.R. Foundation for Statistical Computing; 2006;
  27. Therkildsen MH, Christensen M, Andersen LJ, Schiødt T, Hansen HS. Salivary gland carcinomas-prognostic factors. Acta Oncol. 1998;37(7–8):701–713
  28. North CA, Lee DJ, Piantadosi S, Zahurak M, Johns ME. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1990;18(6):1319–1326
  29. Jones AS, Beasley NJ, Houghton DJ, Helliwell TR, Husband DJ. Tumors of the minor salivary glands. Clin Otolaryngol Allied Sci. 1998;23(1):27–33
  30. Lopes MA, Santos GC, Kowalski LP. Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck. 1998;20(8):699–706
  31. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. Management of minor salivary gland carcinomas. Int J Radiat Oncol Biol Phys. 1996;35(3):443–454
  32. Frankenthaler RA, Luna MA, Lee SS, Ang KK, Byers RM, Guillamondegui OM, et al. Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg. 1991;117(11):1251–1256
  33. Gallo O, Franchi A, Bottai GV, Fini-Storchi I, Tesi G, Boddi V. Risk factors for distant metastases from carcinoma of the parotid gland. Cancer. 1997;80(5):844–851
  34. Garden AS, El-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ. Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys. 1997;37(1):79–85
  35. Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary parotid malignancies. A clinical and pathologic review. Arch Otolaryngol Head Neck Surg. 1991;117(3):307–315
  36. Poulsen MG, Pratt GR, Kynaston B, Tripcony LB. Prognostic variables in malignant epithelial tumors of the parotid. Int J Radiat Oncol Biol Phys. 1992;23(2):327–332
  37. Theriault C, Fitzpatrick PJ. Malignant parotid tumors. Prognostic factors and optimum treatment. Am J Clin Oncol. 1986;9(6):510–516
  38. Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, et al. Mucoepidermoid carcinoma. A clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25(7):835–845
  39. Renehan A, Gleave EN, Hancock BD, Smith P, McGurk M. Long term follow-up of over 1000 patients with salivary gland tumours treated in a single centre. Br J Surg. 1996;83(12):1750–1754
  40. Aro K, Leivo I, Makitie AA. Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: a single institution’s 30-year experience. Laryngoscope. 2008;118(2):258–262

PII: S1368-8375(10)00190-9

doi: 10.1016/j.oraloncology.2010.06.007

Oral Oncology
Volume 46, Issue 9 , Pages 662-666 , September 2010

Article Tools

* Image Usage & Resolution